Micardis and Juvisync drug interactions - a phase IV clinical study of FDA data
Summary:
We study 27,621 people who take Micardis (telmisartan) and Juvisync (simvastatin; sitagliptin phosphate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Micardis and Juvisync. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Micardis?
Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.
What is Juvisync?
Juvisync has active ingredients of simvastatin; sitagliptin phosphate. eHealthMe is studying from 16 Juvisync users. Check the latest studies of Juvisync.
No report is found.
Do you take Micardis and Juvisync?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan and simvastatin; sitagliptin phosphate (the active ingredients of Micardis and Juvisync, respectively), and Micardis and Juvisync (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Coreg and Dipyridamole - now
- Drug interactions of Arimidex and Hydroxyzine Hydrochloride - 9 seconds ago
- Drug interactions of Oxycodone and Eptifibatide - 32 seconds ago
- Could Restasis cause Blood Pressure Systolic Abnormal? - 32 seconds ago
- Drug interactions of Precedex and Heparin - 32 seconds ago
- Could Herceptin cause Hypotension? - 37 seconds ago
- Drug interactions of Trazodone Hydrochloride and Excedrin - 40 seconds ago
- Drug interactions of Altace and Micronase - 41 seconds ago
- Drug interactions of Dexrazoxane and Lopurin - 45 seconds ago
- Histamine Phosphate vs. Xolair, side effect and effectiveness comparison - 45 seconds ago